- Home
- IVVD vs ZUMZ Comparison
IVVD vs ZUMZ Comparison
Compare IVVD & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- ZUMZ
- Stock Information
- Founded
- IVVD 2020
- ZUMZ 1978
- Country
- IVVD United States
- ZUMZ United States
- Employees
- IVVD N/A
- ZUMZ N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- ZUMZ Clothing/Shoe/Accessory Stores
- Sector
- IVVD Health Care
- ZUMZ Consumer Discretionary
- Exchange
- IVVD Nasdaq
- ZUMZ Nasdaq
- Market Cap
- IVVD 412.6M
- ZUMZ 363.1M
- IPO Year
- IVVD 2021
- ZUMZ 2005
- Fundamental
- Price
- IVVD $2.57
- ZUMZ $23.62
- Analyst Decision
- IVVD Strong Buy
- ZUMZ Hold
- Analyst Count
- IVVD 5
- ZUMZ 1
- Target Price
- IVVD $6.11
- ZUMZ $18.00
- AVG Volume (30 Days)
- IVVD 11.9M
- ZUMZ 179.7K
- Earning Date
- IVVD 11-06-2025
- ZUMZ 12-04-2025
- Dividend Yield
- IVVD N/A
- ZUMZ N/A
- EPS Growth
- IVVD N/A
- ZUMZ N/A
- EPS
- IVVD N/A
- ZUMZ 0.03
- Revenue
- IVVD $50,039,000.00
- ZUMZ $900,253,000.00
- Revenue This Year
- IVVD $102.11
- ZUMZ $5.50
- Revenue Next Year
- IVVD $151.51
- ZUMZ $1.36
- P/E Ratio
- IVVD N/A
- ZUMZ $692.93
- Revenue Growth
- IVVD 332.71
- ZUMZ 1.64
- 52 Week Low
- IVVD $0.35
- ZUMZ $11.31
- 52 Week High
- IVVD $3.07
- ZUMZ $24.37
- Technical
- Relative Strength Index (RSI)
- IVVD 64.50
- ZUMZ 64.79
- Support Level
- IVVD $2.38
- ZUMZ $21.84
- Resistance Level
- IVVD $2.70
- ZUMZ $22.91
- Average True Range (ATR)
- IVVD 0.25
- ZUMZ 0.90
- MACD
- IVVD 0.07
- ZUMZ -0.01
- Stochastic Oscillator
- IVVD 69.01
- ZUMZ 90.55
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.